Levels of FasL were significantly increased in lung homogenates upon infection and one day after treatment with mFas-Fc, i.e. at 3 dpi, FasL levels were already decreased when compared to infected mice treated with Control-Fc (Fig. 5f). The gene discussed is FASLG; the disease is infection.